U-PMCB

Q:PMCB - PHARMACYTE BIOTECH INC - https://www.pharmacytebiotech.com

11:05:57 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PMCB - Q	0.2	0.76	·	0.805	0.4	0.7561	-0.0039	-0.5	19.1	14	36	0.76 0.7899 0.7561	1.51 0.63	10:41:49	Nov 25	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 36

More trades...

Time ET	Ex	Price	Change	Volume
10:41:49	Q	0.773	0.013	5
10:41:32	Q	0.761	0.001	8
10:40:37	Q	0.7561	-0.0039	3,000
10:32:36	Q	0.7738	0.0138	100
10:31:58	Q	0.7738	0.0138	7
10:31:31	Q	0.77	0.01	400
10:21:44	Q	0.773	0.013	6
10:21:25	Q	0.7619	0.0019	100
10:21:25	Q	0.7619	0.0019	100
10:20:14	Q	0.776	0.016	5

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-25 09:15	U:PMCB	News Release200	PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
2025-09-02 09:20	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
2025-08-20 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
2025-08-18 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Date ET

Symbol

Type

Headline

2025-11-25 09:15

U:PMCB

News Release

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

2025-09-02 09:20

U:PMCB

News Release

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications